Cohort Studymoderate evidence
Increased buprenorphine prescribing following implementation of a low-barrier virtual prescriber network.
Journal of substance use and addiction treatment·September 15, 2026·PMID 42744115
Why it mattersDespite federal policy changes, buprenorphine prescribing has stagnated nationally. This study provides real-world evidence that a municipal, low-threshold, rapid-access model can significantly expand buprenorphine dispensing, offering a scalable strategy for addiction medicine and internal medicine clinicians to improve opioid use disorder treatment access.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled